{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T10:57:33Z","timestamp":1760266653866},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1998,3,1]],"date-time":"1998-03-01T00:00:00Z","timestamp":888710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Surgical Oncology"],"published-print":{"date-parts":[[1998,3]]},"DOI":"10.1007\/bf02303846","type":"journal-article","created":{"date-parts":[[2006,2,14]],"date-time":"2006-02-14T21:18:02Z","timestamp":1139951882000},"page":"131-139","source":"Crossref","is-referenced-by-count":16,"title":["Axillary lymph node dissection for breast cancer: A decision analysis of T1 lesions"],"prefix":"10.1007","volume":"5","author":[{"given":"Vic","family":"Velanovich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02303846_CR1","first-page":"245","volume":"180","author":"WK Ruffin","year":"1995","unstructured":"Ruffin WK, Stacey-Clear A, Younger J, Hoover HC. Rationale for routine axillary dissection in carcinoma of the breast.J Am Coll Surg 1995;180:245\u201351.","journal-title":"J Am Coll Surg"},{"key":"BF02303846_CR2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/1097-0142(19940201)73:3<505::AID-CNCR2820730302>3.0.CO;2-B","volume":"73","author":"B Cady","year":"1994","unstructured":"Cady B. The need to reexamine axillary lymph node dissection in invasive breast cancer.Cancer 1994;73:505\u20138.","journal-title":"Cancer"},{"key":"BF02303846_CR3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/jso.2930480402","volume":"48","author":"PJ Deckers","year":"1991","unstructured":"Deckers PJ. Axillary dissection in breast cancer: When, why, how much, and for how long? Another operation soon to be extinct?J Surg Oncol 1991;48:217\u20139.","journal-title":"J Surg Oncol"},{"key":"BF02303846_CR4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/BF00348200","volume":"18","author":"NE Davidson","year":"1994","unstructured":"Davidson NE, Abeloff MD. Adjuvant therapy of breast cancer.World J Surg 1994;18:112\u20136.","journal-title":"World J Surg"},{"key":"BF02303846_CR5","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/1097-0142(19940201)73:3<664::AID-CNCR2820730326>3.0.CO;2-S","volume":"73","author":"MJ Silverstein","year":"1994","unstructured":"Silverstein MJ, Gierson ED, Waisman JR, Senofsky GM, Colburn WJ, Gamagani P. Axillary lymph node dissection for T1a breast carcinoma: Is it indicated?Cancer 1994;73:664\u20137.","journal-title":"Cancer"},{"key":"BF02303846_CR6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0002-9610(89)90645-4","volume":"157","author":"V Reger","year":"1989","unstructured":"Reger V, Beito G, Jolly PC. Factors affecting the incidence of lymph node metastases in small cancers of the breast.Am J Surg 1989;157:501\u20132.","journal-title":"Am J Surg"},{"key":"BF02303846_CR7","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/archsurg.1993.01420240023002","volume":"128","author":"BG Haffty","year":"1993","unstructured":"Haffty BG, McKhann C, Beinfield M, Fischer D, Fischer JJ. Breast conservation therapy without axillary dissection: A rationale treatment strategy in selected patients.Arch Surg 1993;128:1315\u20139.","journal-title":"Arch Surg"},{"key":"BF02303846_CR8","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1200\/JCO.1993.11.8.1536","volume":"11","author":"PP Lin","year":"1993","unstructured":"Lin PP, Allison DC, Wainstock J, Miller KD, Dooley WC, Friedman N, Baker RR. Impact of axillary lymph node dissection on the therapy of breast cancer patients.J Clin Oncol 1993:11:1536\u201344.","journal-title":"J Clin Oncol"},{"key":"BF02303846_CR9","first-page":"185","volume":"183","author":"AE Giuliano","year":"1996","unstructured":"Giuliano AE, Barth AM, Spivack B, Beitsch PD, Evans SW. Incidence and predictors of axillary metastasis in T1 carcinoma of the breast.J Am Coll Surg 1996;183:185\u20139.","journal-title":"J Am Coll Surg"},{"key":"BF02303846_CR10","first-page":"207","volume":"217","author":"CM Balch","year":"1993","unstructured":"Balch CM, Singletary SE, Bland KI. Clinical decision-making in early breast cancer.Ann Surg 1993;217:207\u201325.","journal-title":"Ann Surg"},{"key":"BF02303846_CR11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00000658-199408000-00003","volume":"220","author":"TJ Eberlein","year":"1994","unstructured":"Eberlein TJ. Current management of carcinoma of the breast.Ann Surg 1994;220:121\u201336.","journal-title":"Ann Surg"},{"key":"BF02303846_CR12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3322\/canjclin.45.4.199","volume":"45","author":"GN Hortobagyi","year":"1995","unstructured":"Hortobagyi GN, Bazdur AU. Current status of adjuvant systemic therapy for primary breast cancer: Progress and controversy.CA Cancer J Clin 1995;45:199\u2013226.","journal-title":"CA Cancer J Clin"},{"key":"BF02303846_CR13","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1200\/JCO.1992.10.3.428","volume":"10","author":"GM Clark","year":"1992","unstructured":"Clark GM, Mathieu M-C, Owens MA, et al. Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients.J Clin Oncol 1992;10:428\u201332.","journal-title":"J Clin Oncol"},{"key":"BF02303846_CR14","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/0140-6736(92)93150-L","volume":"340","author":"ER Horak","year":"1992","unstructured":"Horak ER, Leek R, Klenk N, et al. Angiogenesis, assessed by platelet\/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer.Lancet 1992;340:1120\u20134.","journal-title":"Lancet"},{"key":"BF02303846_CR15","first-page":"259","volume":"110","author":"AM Davidoff","year":"1991","unstructured":"Davidoff AM, Herndon JE II, Glover NS, Kerns BM, Pence JC, Iglehart D, Marks JR. Relation between p53 overexpression and established prognostic factors in breast cancer.Surgery 1991;110:259\u201364.","journal-title":"Surgery"},{"key":"BF02303846_CR16","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1002\/1097-0142(19931215)72:12<3641::AID-CNCR2820721215>3.0.CO;2-8","volume":"72","author":"K Friedrichs","year":"1993","unstructured":"Friedrichs K, Gluba S, Eidtmann H, Jonat W. Overexpression of p53 and prognosis in breast cancer.Cancer 1993;72;3641\u20137.","journal-title":"Cancer"},{"key":"BF02303846_CR17","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/bjc.1991.100","volume":"63","author":"WJ Gullick","year":"1991","unstructured":"Gullick WJ, Love SB, Wright C, Barnes DM, Gusterson B, Harris AL, Altman DG. c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes.Br J Cancer 1991;63:434\u20138.","journal-title":"Br J Cancer"},{"key":"BF02303846_CR18","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00000658-199404000-00002","volume":"219","author":"JR Marks","year":"1994","unstructured":"Marks JR, Humphrey PA, Wu K, Berry D, Bandarenko N, Kerns BM, Iglehart JD. Overexpression of p53 and HER-2\/neu proteins as prognostic markers in early stage breast cancer.Ann Surg 1994;219:332\u201341.","journal-title":"Ann Surg"},{"key":"BF02303846_CR19","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/1097-0142(19930315)71:6<2006::AID-CNCR2820710614>3.0.CO;2-Q","volume":"71","author":"P Pujol","year":"1993","unstructured":"Pujol P, Maudelonde T, Daures J-P, Rouanet P, Brouillet J-P, Pujol H, Rochefort H. A prospective study of the prognostic value of cathespin D levels in breast cancer cytosol.Cancer 1993;71:2006\u201312.","journal-title":"Cancer"},{"key":"BF02303846_CR20","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1200\/JCO.1994.12.3.454","volume":"12","author":"G Gasparini","year":"1994","unstructured":"Gasparini G, Wiedner N, Bevilacqua P, et al. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.J Clin Oncol 1994;12:454\u201366.","journal-title":"J Clin Oncol"},{"key":"BF02303846_CR21","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0002-9343(82)90786-0","volume":"73","author":"R Beck","year":"1982","unstructured":"Beck R, Kassirer JP, Pauker SG. Convenient approximation of life expectancy (the DEALE): Validation of the method.Am J Med 1982;73:883\u20138.","journal-title":"Am J Med"},{"key":"BF02303846_CR22","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/0002-9343(82)90787-2","volume":"73","author":"R Beck","year":"1982","unstructured":"Beck R, Pauker SG, Gottlieb E, Klein J, Kassirer JP. Convenient approximation of life expectancy (the DEALE): utility in medical decision making.Am J Med 1982;73:889\u201397.","journal-title":"Am J Med"},{"key":"BF02303846_CR23","volume-title":"Clinical Decision Analysis","author":"MC Weinstein","year":"1980","unstructured":"Weinstein MC, Fineberg HV.Clinical Decision Analysis. Philadelphia: WB Saunders, 1980."},{"key":"BF02303846_CR24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0140-6736(92)90997-H","volume":"339","author":"Early Breast Cancer Trialists' Collaborative Group","year":"1992","unstructured":"Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy.Lancet 1992;339:71\u201385.","journal-title":"Lancet"},{"key":"BF02303846_CR25","first-page":"701","volume-title":"The breast","author":"JS Horsley","year":"1991","unstructured":"Horsley JS, Styblo T. Lymphedema in the postmastectomy patient. In: Bland KI, Copeland EM III, eds.The breast. Philadelphia: WB Saunders, 1991:701\u20136."},{"key":"BF02303846_CR26","first-page":"79","volume-title":"Atlas of breast surgery","author":"SA Wells Jr","year":"1994","unstructured":"Wells SA Jr, Young VL, Andriole DA.Atlas of breast surgery. St. Louis: Mosby, 1994:79\u201385."},{"key":"BF02303846_CR27","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/1097-0142(19940115)73:2<350::AID-CNCR2820730219>3.0.CO;2-5","volume":"73","author":"M Chadha","year":"1994","unstructured":"Chadha M, Chabon AB, Friedman P, Vikram B. Predictors of axillary lymph node metastasis in patients with T1 breast cancer: a multivariate analysis.Cancer 1994;73:350\u20133.","journal-title":"Cancer"},{"key":"BF02303846_CR28","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/BF02306375","volume":"2","author":"K Dowlatshahi","year":"1995","unstructured":"Dowlatshahi K, Snider HC, Kim R. Axillary node status in nonpalpable breast cancer.Ann Surg Oncol 1995;2:424\u20138.","journal-title":"Ann Surg Oncol"},{"key":"BF02303846_CR29","first-page":"817","volume-title":"The breast","author":"MJ Anderson","year":"1991","unstructured":"Anderson MJ, Kramer BS. Adjuvant systemic therapy for early stage breast cancer. In: Bland KI, Copeland EM III, eds.The breast. Philadelphia: WB Saunders, 1991:817\u201342."},{"key":"BF02303846_CR30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00348190","volume":"18","author":"WC Wood","year":"1994","unstructured":"Wood WC. Integration of risk factors to allow patient selection for adjuvant systemic therapy in lymph node-negative breast cancer patients.World J Surg 1994;18:39\u201344.","journal-title":"World J Surg"},{"key":"BF02303846_CR31","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1056\/NEJM198902233200801","volume":"320","author":"B Fisher","year":"1989","unstructured":"Fisher B, Redmond C, Dimitrov N, et al. A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors.N Engl J Med 1989;320:473\u20138.","journal-title":"N Engl J Med"},{"key":"BF02303846_CR32","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1056\/NEJM199101173240305","volume":"324","author":"BE Hillner","year":"1991","unstructured":"Hillner BE, Smith TJ. Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer.N Engl J Med 1991;324:160\u20138.","journal-title":"N Engl J Med"},{"key":"BF02303846_CR33","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJM198902233200804","volume":"320","author":"The Ludwig Breast Cancer Study Group","year":"1989","unstructured":"The Ludwig Breast Cancer Study Group. Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer.N Engl J Med 1989;320:491\u20136.","journal-title":"N Engl J Med"},{"key":"BF02303846_CR34","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM198902233200803","volume":"320","author":"EG Mansour","year":"1989","unstructured":"Mansour EG, Gray R, Shatila AH, et al. Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer: An intergroup study.N Engl J Med 1989;320:485\u201390.","journal-title":"N Engl J Med"},{"key":"BF02303846_CR35","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1056\/NEJM199206253262607","volume":"326","author":"WL McGuire","year":"1992","unstructured":"McGuire WL, Clark GM. Prognostic factors and treatment decisions in axillary node-negative breast cancer.N Engl J Med 1992;326:1756\u201361.","journal-title":"N Engl J Med"},{"key":"BF02303846_CR36","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1056\/NEJM199405053301802","volume":"330","author":"HB Muss","year":"1994","unstructured":"Muss HB, Thor AD, Berry DA, et al. c-erb-B-2 expression and response to adjuvant therapy in women with node-positive early breast cancer.N Engl J Med 1994;330:1260\u20136.","journal-title":"N Engl J Med"},{"issue":"Suppl B","key":"BF02303846_CR37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0305-7372(93)90007-E","volume":"19","author":"JGM Klijn","year":"1993","unstructured":"Klijn JGM, Berns EMJJ, Bontenbal M, Foekens J. Cell biological factors associated with the response of breast cancer to systemic treatment.Cancer Treat Rev 1993;19(Suppl B):45\u201363.","journal-title":"Cancer Treat Rev"},{"key":"BF02303846_CR38","unstructured":"Velanovich V. Biologic tumor markers, lymph node status, and decisions about adjuvant chemotherapy for breast cancer. Presented at the 64th Annual Scientific Meeting of the Southeastern Surgical Congress, Tampa, FL, February 5, 1996."},{"key":"BF02303846_CR39","first-page":"159","volume":"159","author":"SB Christensen","year":"1993","unstructured":"Christensen SB, Jansson C. Axillary biopsy compared with dissection in the staging of lymph nodes in operable breast cancer: A randomized trial.Eur J Surg 1993;159:159\u201362.","journal-title":"Eur J Surg"},{"key":"BF02303846_CR40","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/bjs.1800811117","volume":"81","author":"DJ Hadjiminas","year":"1994","unstructured":"Hadjiminas DJ, Burke M. Intraoperative assessment of nodal status in the selection in the selection of patients with breast cancer for axillary clearance.Br J Surg 1994;81:1615\u20136.","journal-title":"Br J Surg"},{"key":"BF02303846_CR41","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00000658-199509000-00016","volume":"222","author":"AE Giuliano","year":"1995","unstructured":"Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy.Ann Surg 1995;222:394\u2013401.","journal-title":"Ann Surg"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02303846.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02303846\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02303846","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T15:59:40Z","timestamp":1557935980000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02303846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,3]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,3]]}},"alternative-id":["BF02303846"],"URL":"https:\/\/doi.org\/10.1007\/bf02303846","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,3]]}}}